Agile Therapeutics, Inc.

Agile Therapeutics, Inc. is a women's healthcare company specializing in the research, development, and commercialization of prescription contraceptive products in the United States. Its flagship product, Twirla (AG200-15), is a once-weekly combination hormonal contraceptive patch. The company also focuses on developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER) and AG200-15 smaller patch (SmP) to enhance contraceptive efficacy and provide shorter and lighter withdrawal bleeds. Additionally, Agile Therapeutics is working on P-Patch, a progestin-only contraceptive patch for women unable or unwilling to take estrogen.

Products

• Twirla (AG200-15) contraceptive patch

• AG200-15 Extended Regimen (ER)

• AG200-15 smaller patch (SmP)

• P-Patch progestin-only contraceptive patch